Erick Wolf of Innolytics, LLC in the U.S. will test a modified version of a drug currently approved as an anti-protozoal and contraceptive for avians for its ability to alter sperm receptor proteins in mammals. If successful, this drug might be used as an oral, non-hormonal and reversible contraceptive.
Grant ID
OPP1017960
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False